Iodinated Contrast Media Market Size is predicted to devean 5.8% CAGR during the forecast period for 2025-2034.
Iodinated contrast media (ICM) are medical imaging agents that contain iodine, which strongly absorbs X-rays. When injected into the body, they make blood vessels, organs, and tissues appear more clearly on X-ray and CT scans. Modern non-ionic, low-osmolar formulations are widely used because they provide high-quality images with fewer side effects. In order to diagnose problems like cancer, gastrointestinal ailments, and cardiovascular diseases, they are crucial since they aid in the differentiation of normal and pathological tissues.
Over the projected period, the market for iodinated contrast media is estimated to grow due to the increasing occurances of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders.
The ongoing development of imaging technologies is another primary factor propelling the iodinated contrast media market's expansion. Minimally invasive diagnostic techniques are being used more and more by healthcare professionals to improve patient outcomes and shorten recovery periods. Additionally, the industry is also expanding due in large part to growing awareness of early disease diagnosis and the increasing use of iodinated contrast agents in emerging nations. Furthermore, this market growth trajectory is expected to be maintained in the next years due to rising investments in healthcare infrastructure and a wider acceptance of radiology services worldwide.
The iodinated contrast media market is segmented by route of administration, agent type, application, application, range, and end-use. The route of administration segment comprises oral, intra-arterial (ia), intravenous (iv), rectal, and others. By agent type, the market is segmented into ionic, non-ionic, and others. By application, the market is segmented into general surgery, oncology, cardiology, neurology, gastroenterology, and others. By end-use, the market is segmented into hospitals and clinics, ambulatory surgical centers (ascs), diagnostic imaging centers, and others.
In 2024, the intravenous (IV) segment became the market leader because of its broad applicability, increasing scan volumes, ongoing innovations, and unwavering developments. Since they are essential for increasing imaging precision during CT, X-ray, MRI, and ultrasound exams, the IV iodinated contrast media segment is the backbone of the market. Furthermore, intravenous iodinated contrast agents significantly improve the visibility of soft tissue and vascular structures during CT and X-ray exams. According to a World Health Organization (WHO) research, there is a huge demand for IV iodinated contrast media, with 3.6 billion diagnostic exams conducted annually, including 350 million on children under the age of 15.
The growing global burden of neurological diseases and the growing need for sophisticated imaging led to the neurological disorders sector being the market leader in 2024. Imaging demand is being driven by conditions such as epilepsy, Parkinson's, Alzheimer's, and stroke. In neurology, stroke imaging is also one of the most common uses of iodinated contrast media. The growth of the neurology segment will be accelerated by this in the iodinated contrast media market.
The iodinated contrast media market is led by North America because to its sophisticated healthcare system and rising rates of chronic illnesses. Additionally, the rise in Alzheimer's disease cases in the US and other nervous system disorders raises the need for iodinated contrast media throughout imaging facilities as a result of the need to track the evolution of various diseases.
In the market for iodinated contrast media, Asia-Pacific is expected to grow at the fastest rate during the forecast period. The rapid development of this industry can be attributed to a number of causes, including growing urbanization, better healthcare infrastructure, a large and aging patient base, a rise in medical tourism, and rising disposable incomes that make healthcare more accessible. Additionally, China is anticipated to have the largest share due to growing investments in healthcare infrastructure.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 5.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Route of Administration, By Agent Type, By Application, By End-use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; Germany; The UK; France; Italy; Spain; Rest of Europe; China; Japan; India; South Korea; Southeast Asia; Rest of Asia Pacific; Brazil; Argentina; Mexico; Rest of Latin America; GCC Countries; South Africa; Rest of the Middle East and Africa |
|
Competitive Landscape |
JB Pharma, GE Healthcare, Trivitron Healthcare, Bayer AG, Bracco, Fujifilm Holdings, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lantheus, Guerbet, and Zhejiang Starry Pharmaceutical Co., Ltd., and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Iodinated Contrast Media Market Snapshot
Chapter 4. Global Iodinated Contrast Media Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Iodinated Contrast Media Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on IODINATED CONTRAST MEDIA MARKET Industry Trends
Chapter 5. Iodinated Contrast Media Market Segmentation 1: By Agent Type, Estimates & Trend Analysis
5.1. Market Share by Agent Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Agent Type:
5.2.1. Non-Ionic
5.2.2. Ionic
5.2.3. Others
Chapter 6. Iodinated Contrast Media Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Cardiology
6.2.2. Neurology
6.2.3. General Surgery
6.2.4. Oncology
6.2.5. Gastroenterology
6.2.6. Others
Chapter 7. Iodinated Contrast Media Market Segmentation 3: By Route of Administration, Estimates & Trend Analysis
7.1. Market Share by Route of Administration, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Route of Administration:
7.2.1. Intravenous (IV)
7.2.2. Intra-arterial (IA)
7.2.3. Oral
7.2.4. Rectal
7.2.5. Others
Chapter 8. Iodinated Contrast Media Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals and Clinics
8.2.2. Diagnostic Imaging Centers
8.2.3. Ambulatory Surgical Centers (ASCs)
8.2.4. Others
Chapter 9. Iodinated Contrast Media Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Iodinated Contrast Media Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Agent Type, 2021-2034
9.2.3. North America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.2.5. North America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Agent Type, 2021-2034
9.3.3. Europe Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.3.5. Europe Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Agent Type, 2021-2034
9.4.3. Asia Pacific Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.4.5. Asia Pacific Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Agent Type, 2021-2034
9.5.3. Latin America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.5.5. Latin America Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Agent Type, 2021-2034
9.6.3. Middle East & Africa Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.6.5. Middle East & Africa Iodinated Contrast Media Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. GE Healthcare
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Bayer AG
10.2.3. Bracco
10.2.4. Lantheus
10.2.5. Guerbet
10.2.6. Fujifilm Holdings
10.2.7. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10.2.8. Zhejiang Starry Pharmaceutical Co., Ltd.
10.2.9. JB Pharma
10.2.10. Trivitron Healthcare
10.2.11. Other Prominent Players
Iodinated Contrast Media Market by Route of Administration-
Iodinated Contrast Media Market by Agent Type -
Iodinated Contrast Media Market by Application-
Iodinated Contrast Media Market by End-use-
Iodinated Contrast Media Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
